Skip to main content
Công ty Cổ phần Dược phẩm Imexpharm logo

Công ty Cổ phần Dược phẩm Imexpharm — Investor Relations & Filings

Ticker · IMP ISIN · VN000000IMP0 HSX Manufacturing
Open in API
Filings indexed 382 across all filing types
Latest filing 2023-12-19 Board/Management Inform…
Country VN Viet Nam
Listing HSX IMP

About Công ty Cổ phần Dược phẩm Imexpharm

www.imexpharm.com

Imexpharm Corporation is a prominent pharmaceutical company with over 48 years of experience in the manufacturing, compounding, and distribution of high-quality pharmaceutical products. The company operates extensive production facilities, including three EU-GMP certified factory clusters and one WHO-GMP certified cluster, making it a leader in EU-GMP compliant manufacturing. Imexpharm is recognized as a top producer of antibiotics and offers a diverse product portfolio encompassing injectable and oral antibiotics, cardiovascular, ophthalmic, musculoskeletal, respiratory, and digestive system treatments, alongside vitamins, minerals, and health protection foods. With 28 product registrations for 11 products in Europe, Imexpharm is dedicated to delivering effective and safe healthcare solutions to the community.

Recent filings

Filing Released Lang Actions
IMP: Thông báo thay đổi nhân sự công ty
Board/Management Information Classification · 92% confidence The document is an irregular disclosure filed on the State Securities Commission and Ho Chi Minh Stock Exchange portals announcing a change in personnel, specifically the appointment of an independent board member. It is clearly an announcement of changes in senior management/board composition rather than a financial report, earnings release, or voting results. Therefore, it falls under the Board/Management Information category (MANG).
2023-12-19 Vietnamese
IMP: Nghị quyết và Biên bản kiểm phiếu ĐHĐCĐ lấy ý kiến cổ đông bằng văn bản
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a formal disclosure on the State Securities Commission and stock exchange portal of Imexpharm’s minutes of vote counting and the resolution of the General Meeting of Shareholders (GMS) held by written opinion. It details the total votes, valid/invalid votes, and the voting outcomes on specific issues. This matches the definition for Declaration of Voting Results & Voting Rights Announcements (Code: DVA).
2023-12-19 Vietnamese
IMP: Tài liệu lấy ý kiến cổ đông bằng văn bản
Proxy Solicitation & Information Statement Classification · 90% confidence The document is an irregular disclosure (not a periodic financial report) announcing and providing the materials (agenda, proposals, draft resolutions, voting slips, explanatory notes) for collecting written shareholder opinions on resolutions to be adopted by the General Meeting of Shareholders. It is clearly intended to solicit votes and inform shareholders of the items up for vote (e.g., election of an independent director, ESOP cancellation, cash bonus plan, use of equity). This matches the definition of a Proxy Solicitation & Information Statement (PSI), which includes materials sent to shareholders to provide information and request votes for meetings.
2023-11-27 Vietnamese
IMP: Thông báo ngày ĐKCC lấy ý kiến cổ đông bằng văn bản
Regulatory Filings Classification · 82% confidence The document is an official notice from the Ho Chi Minh City Stock Exchange announcing the record date (“ngày đăng ký cuối cùng”) and ex-rights date for shareholders’ voting rights on written resolutions. It is not a financial report, proxy statement, or dividend announcement but a general regulatory announcement concerning shareholder procedures. This fits the fallback category Regulatory Filings (RNS).
2023-11-09 Vietnamese
IMP: Thông báo thay đổi giấy chứng nhận ĐKDN lần thứ 31
Regulatory Filings Classification · 90% confidence The document is a routine 24-hour disclosure to the State Securities Commission and the Stock Exchange announcing the company’s updated Enterprise Registration Certificate (31st change). It contains no financial statements, management discussion, or investor presentation; rather it is a regulatory announcement of corporate registration details. This fits the “Regulatory Filings (RNS)” category as a general compliance disclosure that does not match any more specific category.
2023-11-08 Vietnamese
IMP: Quyết định xử phạt vi phạm hành chính về thuế
Legal Proceedings Report Classification · 90% confidence The document is a 24‐hour disclosure on the Vietnamese State Securities Commission and Ho Chi Minh Stock Exchange portals, reporting an administrative penalty decision (tax violation fine) against Imexpharm. It is not a financial report, board change, earnings release, or management statement, but rather a regulatory/legal action announcement. This matches the definition of a Legal Proceedings Report (Code: LTR) covering regulatory actions or legal matters involving the company.
2023-11-08 Vietnamese

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.